# Subcutaneous Botulinum Toxin for Cutaneous Allodynia - Enriched Responder Trial

> **NCT00822926** · NA · TERMINATED · sponsor: **Stanford University** · enrollment: 5 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Botulinum Toxin Type A
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT00822926
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00822926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00822926, "Subcutaneous Botulinum Toxin for Cutaneous Allodynia - Enriched Responder Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00822926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*